Medicaid Subscription-Based Payment Models For Hep C Drugs In Louisiana & Washington State Had A Larger Impact In Louisiana Due To Policy Factors

After Louisiana and Washington State implemented nearly identical Medicaid subscription-based payment models (SBPMs) to expand access to hepatitis C virus (HCV) treatment, due to state policy factors Louisiana's program had a greater impact than Washington's. Both had implemented SBPMs in July 2019. The models were intended to increase screening rates, RNA testing rates, and uptake of direct acting antiviral (DAA) medications among Medicaid managed care enrollees.

Louisiana’s model was associated with a significant increase in all outcomes. RNA testing increased by 35.2 per 100,000 people per month. DAA initiation increased by 7.8 per . . .